位置:首页 > 蛋白库 > KCNC3_MOUSE
KCNC3_MOUSE
ID   KCNC3_MOUSE             Reviewed;         769 AA.
AC   Q63959; D3YZV2; E9Q5E5; Q62088;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   07-OCT-2020, sequence version 3.
DT   03-AUG-2022, entry version 162.
DE   RecName: Full=Potassium voltage-gated channel subfamily C member 3;
DE   AltName: Full=KSHIIID;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3.3;
GN   Name=Kcnc3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=8301351; DOI=10.1523/jneurosci.14-02-00511.1994;
RA   Goldman-Wohl D.S., Chan E., Baird D., Heintz N.;
RT   "Kv3.3b: a novel Shaw type potassium channel expressed in terminally
RT   differentiated cerebellar Purkinje cells and deep cerebellar nuclei.";
RL   J. Neurosci. 14:511-522(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-660.
RC   STRAIN=AKR/J;
RX   PubMed=1740329; DOI=10.1016/0888-7543(92)90365-y;
RA   Ghanshani S., Pak M., McPherson J.D., Strong M., Dethlefs B., Wasmuth J.J.,
RA   Salkoff L.A., Gutman G.A., Chandy G.K.;
RT   "Genomic organization, nucleotide sequence, and cellular distribution of a
RT   Shaw-related potassium channel gene, Kv3.3, and mapping of Kv3.3 and Kv3.4
RT   to human chromosomes 19 and 1.";
RL   Genomics 12:190-196(1992).
RN   [4]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=11517255; DOI=10.1523/jneurosci.21-17-06657.2001;
RA   Espinosa F., McMahon A., Chan E., Wang S., Ho C.S., Heintz N., Joho R.H.;
RT   "Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus
RT   in mice lacking the potassium channels Kv3.1 and Kv3.3.";
RL   J. Neurosci. 21:6657-6665(2001).
RN   [5]
RP   DISRUPTION PHENOTYPE, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15217387; DOI=10.1111/j.0953-816x.2004.03385.x;
RA   McMahon A., Fowler S.C., Perney T.M., Akemann W., Knoepfel T., Joho R.H.;
RT   "Allele-dependent changes of olivocerebellar circuit properties in the
RT   absence of the voltage-gated potassium channels Kv3.1 and Kv3.3.";
RL   Eur. J. Neurosci. 19:3317-3327(2004).
RN   [6]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=16923152; DOI=10.1111/j.1601-183x.2005.00184.x;
RA   Joho R.H., Street C., Matsushita S., Knoepfel T.;
RT   "Behavioral motor dysfunction in Kv3-type potassium channel-deficient
RT   mice.";
RL   Genes Brain Behav. 5:472-482(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=16452087; DOI=10.1074/mcp.t500041-mcp200;
RA   Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L.;
RT   "Comprehensive identification of phosphorylation sites in postsynaptic
RT   density preparations.";
RL   Mol. Cell. Proteomics 5:914-922(2006).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND TISSUE SPECIFICITY.
RX   PubMed=18539595; DOI=10.1074/jbc.m801663200;
RA   Desai R., Kronengold J., Mei J., Forman S.A., Kaczmarek L.K.;
RT   "Protein kinase C modulates inactivation of Kv3.3 channels.";
RL   J. Biol. Chem. 283:22283-22294(2008).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=18448641; DOI=10.1523/jneurosci.5486-07.2008;
RA   Hurlock E.C., McMahon A., Joho R.H.;
RT   "Purkinje-cell-restricted restoration of Kv3.3 function restores complex
RT   spikes and rescues motor coordination in Kcnc3 mutants.";
RL   J. Neurosci. 28:4640-4648(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-687; SER-692; SER-731;
RP   SER-734; SER-742; THR-750 AND SER-754, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ARG-424.
RX   PubMed=24218544; DOI=10.1113/jphysiol.2013.264309;
RA   Irie T., Matsuzaki Y., Sekino Y., Hirai H.;
RT   "Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13
RT   alter excitability and induce cell death in cultured cerebellar Purkinje
RT   cells.";
RL   J. Physiol. (Lond.) 592:229-247(2014).
RN   [12]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-626, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MUTAGENESIS OF GLY-593,
RP   AND INTERACTION WITH HAX1.
RX   PubMed=26997484; DOI=10.1016/j.cell.2016.02.009;
RA   Zhang Y., Zhang X.F., Fleming M.R., Amiri A., El-Hassar L., Surguchev A.A.,
RA   Hyland C., Jenkins D.P., Desai R., Brown M.R., Gazula V.R., Waters M.F.,
RA   Large C.H., Horvath T.L., Navaratnam D., Vaccarino F.M., Forscher P.,
RA   Kaczmarek L.K.;
RT   "Kv3.3 channels bind Hax-1 and Arp2/3 to assemble a stable local actin
RT   network that regulates channel gating.";
RL   Cell 165:434-448(2016).
CC   -!- FUNCTION: Voltage-gated potassium channel that plays an important role
CC       in the rapid repolarization of fast-firing brain neurons. The channel
CC       opens in response to the voltage difference across the membrane,
CC       forming a potassium-selective channel through which potassium ions pass
CC       in accordance with their electrochemical gradient. The channel displays
CC       rapid activation and inactivation kinetics (PubMed:18539595,
CC       PubMed:26997484, PubMed:24218544). It plays a role in the regulation of
CC       the frequency, shape and duration of action potentials in Purkinje
CC       cells (PubMed:15217387, PubMed:18448641, PubMed:24218544). Required for
CC       normal survival of cerebellar neurons, probably via its role in
CC       regulating the duration and frequency of action potentials that in turn
CC       regulate the activity of voltage-gated Ca(2+) channels and cellular
CC       Ca(2+) homeostasis (PubMed:24218544). Required for normal motor
CC       function (PubMed:16923152, PubMed:18448641). Plays a role in the
CC       reorganization of the cortical actin cytoskeleton and the formation of
CC       actin veil structures in neuronal growth cones via its interaction with
CC       HAX1 and the Arp2/3 complex (PubMed:26997484).
CC       {ECO:0000269|PubMed:15217387, ECO:0000269|PubMed:16923152,
CC       ECO:0000269|PubMed:18448641, ECO:0000269|PubMed:18539595,
CC       ECO:0000269|PubMed:24218544, ECO:0000269|PubMed:26997484}.
CC   -!- SUBUNIT: Homotetramer. Heterotetramer with KCNC1 (By similarity).
CC       Interacts (via C-terminus) with HAX1. Identified in a complex with
CC       ACTR3, a subunit of the Arp2/3 complex; this interaction is indirect
CC       and depends on the presence of HAX1. Interaction with HAX1 modulates
CC       channel gating (PubMed:26997484). {ECO:0000250|UniProtKB:Q14003,
CC       ECO:0000269|PubMed:26997484}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15217387,
CC       ECO:0000269|PubMed:18448641, ECO:0000269|PubMed:18539595,
CC       ECO:0000269|PubMed:24218544, ECO:0000269|PubMed:26997484}; Multi-pass
CC       membrane protein {ECO:0000255}. Presynaptic cell membrane
CC       {ECO:0000269|PubMed:26997484}; Multi-pass membrane protein
CC       {ECO:0000255}. Perikaryon {ECO:0000269|PubMed:15217387}. Cell
CC       projection, axon {ECO:0000269|PubMed:15217387}. Cell projection,
CC       dendrite {ECO:0000269|PubMed:15217387}. Cell projection, dendritic
CC       spine membrane {ECO:0000250|UniProtKB:Q01956}; Multi-pass membrane
CC       protein {ECO:0000255}. Cytoplasm, cell cortex
CC       {ECO:0000250|UniProtKB:Q14003}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q14003}. Note=Detected on Purkinje cell
CC       dendritic spines, positioned perisynaptically but also in extrasynaptic
CC       positions along the spine membranes (By similarity). Detected at
CC       presynaptic calices of Held (PubMed:26997484). Colocalizes with the
CC       cortical actin cytoskeleton and the Arp2/3 complex (By similarity).
CC       {ECO:0000250|UniProtKB:Q01956, ECO:0000250|UniProtKB:Q14003}.
CC   -!- TISSUE SPECIFICITY: Detected on Purkinje cells in the dentate,
CC       interposed and medial nucleus in cerebellum (PubMed:15217387,
CC       PubMed:18448641). Detected in brainstem (PubMed:18539595). Detected at
CC       calyces of Held in the auditory brain stem (at protein level)
CC       (PubMed:26997484). Isoform KV3.3B is highly enriched in the brain,
CC       particularly in the cerebellum, where its expression is confined to
CC       Purkinje cells and deep cerebellar nuclei. Isoform KV3.3A is not
CC       expressed in cerebellum. {ECO:0000269|PubMed:15217387,
CC       ECO:0000269|PubMed:18448641, ECO:0000269|PubMed:18539595,
CC       ECO:0000269|PubMed:26997484, ECO:0000269|PubMed:8301351}.
CC   -!- DEVELOPMENTAL STAGE: Expression begins in cerebellar Purkinje cells
CC       between postnatal day 8 (P8) and P10 and continues through adulthood.
CC       {ECO:0000269|PubMed:8301351}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at every
CC       third position. {ECO:0000305}.
CC   -!- DOMAIN: The cytoplasmic N-terminus mediates N-type inactivation.
CC       {ECO:0000269|PubMed:18539595}.
CC   -!- DOMAIN: The C-terminal cytoplasmic tail contributes to the regulation
CC       of channel inactivation and to the interaction with HAX1 and the Arp2/3
CC       complex. {ECO:0000269|PubMed:26997484}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q14003}.
CC   -!- DISRUPTION PHENOTYPE: Mice lacking both Kcnc3 and Kcnc1 are born at the
CC       expected Mendelian rate, but the pups do not thrive and all die about
CC       26 days after birth when kept together with other littermates. Their
CC       failure to thrive may be due to motor problems; mutant pups survive
CC       when fed separately, but 45 days after birth their body weight is only
CC       50 to 60 % of that of wild-type (PubMed:11517255). They appear
CC       uncoordinated and display severe ataxia, myoclonus and spontaneous
CC       whole-body muscle jerks, but display no obvious alterations in brain
CC       morphology (PubMed:11517255, PubMed:15217387, PubMed:16923152). Mice
CC       lacking only Kcnc3 still display ataxic gait and decreased motor skill,
CC       but to a lesser degree than mice lacking both Kcnc3 and Kcnc1
CC       (PubMed:16923152, PubMed:18448641). Purkinje cell-specific expression
CC       of Kcnc3 restores normal motor skills (PubMed:18448641). Mutant mice
CC       are also much more sensitive to ethanol and fall sideways at ethanol
CC       concentrations that have no effect on wild-type mice (PubMed:11517255).
CC       They display increased locomotor and exploratory activity
CC       (PubMed:11517255, PubMed:15217387). Mice lacking Kcnc3 or both Kcnc3
CC       and Kcnc1 are resistant to the tremorogenic agent harmaline
CC       (PubMed:15217387). {ECO:0000269|PubMed:11517255,
CC       ECO:0000269|PubMed:15217387, ECO:0000269|PubMed:16923152,
CC       ECO:0000269|PubMed:18448641}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw) (TC
CC       1.A.1.2) subfamily. Kv3.3/KCNC3 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA43209.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=CAA43209.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact. Incorrect C-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S69381; AAC60679.1; -; mRNA.
DR   EMBL; AC157653; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X60796; CAA43209.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X60797; CAA43209.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS39942.1; -.
DR   PIR; A42073; A42073.
DR   RefSeq; NP_032448.2; NM_008422.2.
DR   AlphaFoldDB; Q63959; -.
DR   SMR; Q63959; -.
DR   STRING; 10090.ENSMUSP00000103539; -.
DR   GlyGen; Q63959; 3 sites.
DR   iPTMnet; Q63959; -.
DR   PhosphoSitePlus; Q63959; -.
DR   SwissPalm; Q63959; -.
DR   MaxQB; Q63959; -.
DR   PaxDb; Q63959; -.
DR   PeptideAtlas; Q63959; -.
DR   PRIDE; Q63959; -.
DR   ProteomicsDB; 263397; -.
DR   ProteomicsDB; 353015; -.
DR   ABCD; Q63959; 1 sequenced antibody.
DR   Antibodypedia; 18827; 305 antibodies from 30 providers.
DR   DNASU; 16504; -.
DR   Ensembl; ENSMUST00000107907; ENSMUSP00000103540; ENSMUSG00000062785.
DR   GeneID; 16504; -.
DR   KEGG; mmu:16504; -.
DR   CTD; 3748; -.
DR   MGI; MGI:96669; Kcnc3.
DR   VEuPathDB; HostDB:ENSMUSG00000062785; -.
DR   eggNOG; KOG3713; Eukaryota.
DR   GeneTree; ENSGT00940000163131; -.
DR   InParanoid; Q63959; -.
DR   OMA; WMIERTS; -.
DR   OrthoDB; 818306at2759; -.
DR   Reactome; R-MMU-1296072; Voltage gated Potassium channels.
DR   BioGRID-ORCS; 16504; 2 hits in 72 CRISPR screens.
DR   PRO; PR:Q63959; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; Q63959; protein.
DR   Bgee; ENSMUSG00000062785; Expressed in cerebellar cortex and 154 other tissues.
DR   ExpressionAtlas; Q63959; baseline and differential.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0030673; C:axolemma; IDA:MGI.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0043679; C:axon terminus; IDA:MGI.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0032590; C:dendrite membrane; IDA:MGI.
DR   GO; GO:0032591; C:dendritic spine membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0099055; C:integral component of postsynaptic membrane; ISO:MGI.
DR   GO; GO:0099056; C:integral component of presynaptic membrane; ISO:MGI.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:MGI.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:MGI.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:MGI.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISS:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0051262; P:protein tetramerization; ISS:UniProtKB.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IEA:UniProtKB-KW.
DR   GO; GO:0046928; P:regulation of neurotransmitter secretion; IMP:MGI.
DR   Gene3D; 1.20.120.350; -; 1.
DR   Gene3D; 3.30.710.10; -; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR005404; K_chnl_volt-dep_Kv3.3.
DR   InterPro; IPR021105; K_chnl_volt-dep_Kv3_ID.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR028325; VG_K_chnl.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR11537; PTHR11537; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF11404; Potassium_chann; 1.
DR   PRINTS; PR01582; KV33CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; SSF54695; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; Cytoplasm; Cytoskeleton; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Methylation; Phosphoprotein;
KW   Postsynaptic cell membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Synapse; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN           1..769
FT                   /note="Potassium voltage-gated channel subfamily C member
FT                   3"
FT                   /id="PRO_0000054056"
FT   TOPO_DOM        1..291
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        292..310
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        352..371
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        372..380
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        381..399
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        413..435
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        436..448
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        449..470
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        519..540
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        541..769
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..80
FT                   /note="Important for normal N-type inactivation"
FT                   /evidence="ECO:0000269|PubMed:18539595"
FT   REGION          8..66
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          202..231
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          557..627
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          679..701
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          746..769
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           504..509
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        22..43
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        566..605
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         626
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         687
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         692
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         731
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         734
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         742
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         750
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         754
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   CARBOHYD        321
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        337
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        484
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         424
FT                   /note="R->H: Loss of channel activity. Functions as
FT                   dominant negative mutation that impairs function of wild-
FT                   type channel subunits. Causes impaired Purkinje cell
FT                   dendrite growth and premature death of cerebellar Purkinje
FT                   cells."
FT                   /evidence="ECO:0000269|PubMed:24218544"
FT   MUTAGEN         593
FT                   /note="G->R: No effect on voltage-dependent channel opening
FT                   or current amplitude, but decreased rate of inactivation
FT                   during prolonged depolarization."
FT                   /evidence="ECO:0000269|PubMed:26997484"
FT   CONFLICT        13
FT                   /note="R -> C (in Ref. 1; AAC60679)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        51..62
FT                   /note="AASPAGAPLSCG -> GPSPGVPAFLR (in Ref. 1; AAC60679)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        257..267
FT                   /note="GPAGGAGGAGG -> DLPGARAAGA (in Ref. 3; CAA43209)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        258..259
FT                   /note="PA -> LP (in Ref. 1; AAC60679)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        522
FT                   /note="A -> G (in Ref. 1; AAC60679 and 3; CAA43209)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        660
FT                   /note="A -> AV (in Ref. 1; AAC60679)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   769 AA;  81946 MW;  E482F3B2216870F5 CRC64;
     MLSSVCVWSF RGRQGTGKQQ PQPVPTPQPP ESSPPPLPPP QQQQCSQPGT AASPAGAPLS
     CGPGGRRAEP CPGLPAVAMG RHGGGGGDSG KIVINVGGVR HETYRSTLRT LPGTRLAGLT
     EPEAAARFDY DPGTDEFFFD RHPGVFAYVL NYYRTGKLHC PADVCGPLFE EELGFWGIDE
     TDVEACCWMT YRQHRDAEEA LDSFEAPDSS ANANANAGGA HDAGLDDEAG AGGGGLDGAG
     GELKRLCFQD AGGGAGGPAG GAGGAGGTWW RRWQPRVWAL FEDPYSSRAA RYVAFASLFF
     ILISITTFCL ETHEGFIHIS NKTVTQASPI PGAPPENITN VEVETEPFLT YVEGVCVVWF
     TFEFLMRVTF CPDKVEFLKS SLNIIDCVAI LPFYLEVGLS GLSSKAAKDV LGFLRVVRFV
     RILRIFKLTR HFVGLRVLGH TLRASTNEFL LLIIFLALGV LIFATMIYYA ERIGADPDDI
     LGSNHTYFKN IPIGFWWAVV TMTTLGYGDM YPKTWSGMLV GALCALAGVL TIAMPVPVIV
     NNFGMYYSLA MAKQKLPKKK NKHIPRPPQP GSPNYCKPDP PPPPPPHPHH GSGGISPPPP
     ITPPSMGVNV AGAYPPGPHT HPGLLRGGAG GLGIMGLPPL PAPGEPCPLA QEEVIETNRA
     DPRPNGDPAA AALAHEDCPA IDQPAMSPED KSPITPGSRG RYSRDRACFL VTDYAPSPDG
     SIRKGYEKSR SLSSIVGLSG VSLRLAPLAT PPGSPRATRR APPTLPSIL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024